Andrew Hardie to Diffusion Magnetic Resonance Imaging
This is a "connection" page, showing publications Andrew Hardie has written about Diffusion Magnetic Resonance Imaging.
Connection Strength
1.455
-
Improved differentiation between hepatic hemangioma and metastases on diffusion-weighted MRI by measurement of standard deviation of apparent diffusion coefficient. Clin Imaging. 2015 Jul-Aug; 39(4):654-8.
Score: 0.405
-
Improved performance of SPECT-CT In-111 capromab pendetide by correlation with diffusion-weighted magnetic resonance imaging for identifying metastatic pelvic lymphadenopathy in prostate cancer. World J Urol. 2013 Dec; 31(6):1327-32.
Score: 0.352
-
Diagnostic accuracy of diffusion-weighted MRI for identifying hepatocellular carcinoma with liver explant correlation. J Med Imaging Radiat Oncol. 2011 Aug; 55(4):362-7.
Score: 0.313
-
Diagnosis of liver metastases: value of diffusion-weighted MRI compared with gadolinium-enhanced MRI. Eur Radiol. 2010 Jun; 20(6):1431-41.
Score: 0.283
-
Can the patient with cirrhosis be imaged for hepatocellular carcinoma without gadolinium?: Comparison of combined T2-weighted, T2*-weighted, and diffusion-weighted MRI with gadolinium-enhanced MRI using liver explantation standard. J Comput Assist Tomogr. 2011 Nov-Dec; 35(6):711-5.
Score: 0.080
-
Utility of quantitative MRI metrics for assessment of stage and grade of urothelial carcinoma of the bladder: preliminary results. AJR Am J Roentgenol. 2013 Dec; 201(6):1254-9.
Score: 0.023